{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T07:22:15Z","timestamp":1792653735687,"version":"4.5.0"},"reference-count":43,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2012,6,13]],"date-time":"2012-06-13T00:00:00Z","timestamp":1339545600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0038853","type":"journal-article","created":{"date-parts":[[2012,6,13]],"date-time":"2012-06-13T21:02:56Z","timestamp":1339621376000},"page":"e38853","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":76,"title":["Humanized Mice Recapitulate Key Features of HIV-1 Infection: A Novel Concept Using Long-Acting Anti-Retroviral Drugs for Treating HIV-1"],"prefix":"10.1371","volume":"7","author":[{"given":"Marc","family":"Nischang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Sutmuller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo","family":"Gers-Huber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Audig\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary-Aude","family":"Rochat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Baenziger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula","family":"Hofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Schlaepfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Regenass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Amssoms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"Stoops","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Van Cauwenberge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Boden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guenter","family":"Kraus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto F.","family":"Speck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,6,13]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1086\/505147","article-title":"The survival benefits of AIDS treatment in the United States.","volume":"194","author":"RP Walensky","year":"2006","journal-title":"J Infect Dis"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1126\/science.1123016","article-title":"Origins of HIV and the evolution of resistance to AIDS.","volume":"313","author":"JL Heeney","year":"2006","journal-title":"Science"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1126\/science.2971269","article-title":"The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function.","volume":"241","author":"JM McCune","year":"1988","journal-title":"Science"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1126\/science.3201256","article-title":"Infection of the SCID-hu mouse by HIV-1.","volume":"242","author":"R Namikawa","year":"1988","journal-title":"Science"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S1357-4310(97)01046-0","article-title":"The SCID-hu mouse: an in vivo model for HIV-1 infection in humans.","volume":"3","author":"ML Bonyhadi","year":"1997","journal-title":"Mol Med Today"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1126\/science.1093933","article-title":"Development of a human adaptive immune system in cord blood cell-transplanted mice.","volume":"304","author":"E Traggiai","year":"2004","journal-title":"Science"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1182\/blood-2008-03-145946","article-title":"FoxP3+CD4+ regulatory T cells play an important role in acute HIV-1 infection in humanized Rag2\u2212\/\u2212gammaC\u2212\/\u2212 mice in vivo.","volume":"112","author":"Q Jiang","year":"2008","journal-title":"Blood"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nri2017","article-title":"Humanized mice in translational biomedical research.","volume":"7","author":"LD Shultz","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"15951","DOI":"10.1073\/pnas.0604493103","article-title":"Disseminated and sustained HIV infection in CD34+ cord blood cell-transplanted Rag2\u2212\/\u2212gamma c\u2212\/\u2212 mice.","volume":"103","author":"S Baenziger","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1742-4690-3-76","article-title":"HIV-1 infection and CD4 T cell depletion in the humanized Rag2\u2212\/\u2212gamma c\u2212\/\u2212 (RAG-hu) mouse model.","volume":"3","author":"BK Berges","year":"2006","journal-title":"Retrovirology"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1182\/blood-2006-04-017681","article-title":"Hematopoietic stem cell-engrafted NOD\/SCID\/IL2Rgamma null mice develop human lymphoid systems and induce long-lasting HIV-1 infection with specific humoral immune responses.","volume":"109","author":"S Watanabe","year":"2007","journal-title":"Blood"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1182\/blood-2006-07-033159","article-title":"HIV-1 infection and pathogenesis in a novel humanized mouse model.","volume":"109","author":"L Zhang","year":"2007","journal-title":"Blood"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1128\/JVI.02010-06","article-title":"Human immunodeficiency virus type 1 pathobiology studied in humanized BALB\/c-Rag2\u2212\/\u2212gammac\u2212\/\u2212 mice.","volume":"81","author":"S Gorantla","year":"2007","journal-title":"J Virol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1089\/aid.2009.0136","article-title":"Highly active antiretroviral therapy potently suppresses HIV infection in humanized Rag2\u2212\/\u2212gammac\u2212\/\u2212 mice.","volume":"26","author":"K Sango","year":"2010","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"8254","DOI":"10.1128\/JVI.00580-09","article-title":"Suppression of human immunodeficiency virus type 1 (HIV-1) viremia with reverse transcriptase and integrase inhibitors, CD4+ T-cell recovery, and viral rebound upon interruption of therapy in a new model for HIV treatment in the humanized Rag2\u2212\/\u2212{gamma}c\u2212\/\u2212 mouse.","volume":"83","author":"SK Choudhary","year":"2009","journal-title":"J Virol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1128\/JVI.05590-11","article-title":"Latent HIV-1 infection of resting CD4 T cells in the humanized Rag2\/ gammac\/ mouse.","volume":"86","author":"SK Choudhary","year":"2012","journal-title":"J Virol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1128\/JVI.06120-11","article-title":"Generation of HIV latency in humanized BLT mice.","volume":"86","author":"PW Denton","year":"2012","journal-title":"J Virol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1128\/JVI.06366-11","article-title":"HIV latency in the humanized BLT mouse.","volume":"86","author":"MD Marsden","year":"2012","journal-title":"J Virol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1182\/blood-2001-12-0207","article-title":"NOD\/SCID\/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells.","volume":"100","author":"M Ito","year":"2002","journal-title":"Blood"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"13259","DOI":"10.1128\/JVI.01353-07","article-title":"Humanized NOD\/SCID\/IL2Rgamma(null) mice transplanted with hematopoietic stem cells under nonmyeloablative conditions show prolonged life spans and allow detailed analysis of human immunodeficiency virus type 1 pathogenesis.","volume":"81","author":"S Watanabe","year":"2007","journal-title":"J Virol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","article-title":"Dose translation from animal to human studies revisited.","volume":"22","author":"S Reagan-Shaw","year":"2008","journal-title":"FASEB J"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0140-6736(11)60992-6","article-title":"Rilpivirine: a step forward in tailored HIV treatment.","volume":"378","author":"R Schrijvers","year":"2011","journal-title":"Lancet"},{"key":"ref23","first-page":"77","article-title":"European recommendations for the clinical use of HIV drug resistance testing: 2011 update.","volume":"13","author":"AM Vandamme","year":"2011","journal-title":"AIDS Rev"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1006\/smim.1996.0028","article-title":"SCID-hu mice: a model for studying disseminated HIV infection.","volume":"8","author":"H Goldstein","year":"1996","journal-title":"Semin Immunol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"e655","DOI":"10.1371\/journal.pone.0000655","article-title":"Validation of the SCID-hu Thy\/Liv mouse model with four classes of licensed antiretrovirals.","volume":"2","author":"CA Stoddart","year":"2007","journal-title":"PLoS ONE"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2165\/11318110-000000000-00000","article-title":"Intracellular Pharmacokinetics of Antiretroviral Drugs in HIV-Infected Patients, and their Correlation with Drug Action.","volume":"49","author":"C Bazzoli","year":"2010","journal-title":"Clin Pharmacokinet"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0140-6736(11)60983-5","article-title":"Rilpivirine versus efavirenz with two background nucleoside or nucleotide reverse transcriptase inhibitors in treatment-naive adults infected with HIV-1 (THRIVE): a phase 3, randomised, non-inferiority trial.","volume":"378","author":"CJ Cohen","year":"2011","journal-title":"Lancet"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0140-6736(11)60936-7","article-title":"Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): a phase 3 randomised double-blind active-controlled trial.","volume":"378","author":"JM Molina","year":"2011","journal-title":"Lancet"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1086\/518250","article-title":"Decay of the HIV reservoir in patients receiving antiretroviral therapy for extended periods: implications for eradication of virus.","volume":"195","author":"TW Chun","year":"2007","journal-title":"J Infect Dis"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.ejpb.2009.03.006","article-title":"Development of a long-acting injectable formulation with nanoparticles of rilpivirine (TMC278) for HIV treatment.","volume":"72","author":"L Baert","year":"2009","journal-title":"Eur J Pharm Biopharm"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1128\/AAC.01529-09","article-title":"Pharmacokinetics and disposition of rilpivirine (TMC278) nanosuspension as a long-acting injectable antiretroviral formulation.","volume":"54","author":"G van't Klooster","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1358\/dot.2011.47.1.1583188","article-title":"Rilpivirine: a new addition to the anti-HIV-1 armamentarium.","volume":"47","author":"CD Miller","year":"2011","journal-title":"Drugs Today (Barc)"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/01.COH.0000410239.88517.00","article-title":"Antiretroviral therapy in treatment-naive patients with HIV infection.","volume":"6","author":"R Camacho","year":"2011","journal-title":"Curr Opin HIV AIDS"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1097\/QAD.0b013e3281c61394","article-title":"Stopping antiretroviral therapy.","volume":"21","author":"S Taylor","year":"2007","journal-title":"AIDS"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1097\/QAD.0b013e328311d16f","article-title":"Viral resuppression and detection of drug resistance following interruption of a suppressive non-nucleoside reverse transcriptase inhibitor-based regimen.","volume":"22","author":"Z Fox","year":"2008","journal-title":"AIDS"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.3851\/IMP1647","article-title":"Raltegravir and unboosted atazanavir dual therapy in virologically suppressed antiretroviral treatment-experienced HIV patients.","volume":"15","author":"DV Cordery","year":"2010","journal-title":"Antivir Ther"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"9693","DOI":"10.1128\/JVI.00492-07","article-title":"Productive human immunodeficiency virus type 1 infection in peripheral blood predominantly takes place in CD4\/CD8 double-negative T lymphocytes.","volume":"81","author":"P Kaiser","year":"2007","journal-title":"J Virol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jviromet.2010.01.012","article-title":"Rational design of HIV-1 fluorescent hydrolysis probes considering phylogenetic variation and probe performance.","volume":"165","author":"CF Althaus","year":"2010","journal-title":"J Virol Methods"},{"key":"ref39","first-page":"630","article-title":"PCR-Based assay to quantify human immunodeficiency virus type 1 DNA in peripheral blood mononuclear cells.","volume":"38","author":"C Christopherson","year":"2000","journal-title":"JClinMicrobiol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"8793","DOI":"10.1128\/JVI.00598-07","article-title":"In vivo and in vitro escape from neutralizing antibodies 2G12, 2F5, and 4E10.","volume":"81","author":"A Manrique","year":"2007","journal-title":"J Virol"},{"key":"ref41","first-page":"138","article-title":"Development and Performance of Conventional HIV-1 Phenotyping (Antivirogram) and Genotype-Based Calculated Phenotyping Assay (virco TYPE HIV-1) on Protease and Reverse Transcriptase Genes to Evaluate Drug Resistance.","author":"YV T. Pattery","year":"2012"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1097\/00002030-200009290-00010","article-title":"Zidovudine triphosphate and lamivudine triphosphate concentration-response relationships in HIV-infected persons.","volume":"14","author":"CV Fletcher","year":"2000","journal-title":"AIDS"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1128\/AAC.50.4.1304-1310.2006","article-title":"Pharmacokinetics of tenofovir disoproxil fumarate and ritonavir-boosted saquinavir mesylate administered alone or in combination at steady state.","volume":"50","author":"GE Chittick","year":"2006","journal-title":"Antimicrob Agents Chemother"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0038853","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T10:12:56Z","timestamp":1714039976000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0038853"}},"subtitle":[],"editor":[{"given":"Cheryl A.","family":"Stoddart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,6,13]]},"references-count":43,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2012,6,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0038853","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,13]]}}}